Aytu BioPharma, Inc. (AYTU) Earnings Call Transcript & Summary

May 21, 2021

NASDAQ US Health Care Pharmaceuticals shareholder_meeting 4 min

Earnings Call Speaker Segments

Joshua Disbrow

executive
#1

Good morning. I'm Josh Disbrow, Chairman and CEO of to Aytu Biopharma, Inc., and it's a pleasure to welcome you to this Annual Meeting of shareholders. The meeting will come to order. The business before this meeting is described in our notice of annual meeting of stockholders and proxy statement, a copy of which has been mailed to our stockholders. This meeting is being held in accordance with Aytu's bylaws and Delaware law. A copy of the agenda and rules of conduct for the meeting has been provided through the web portal. It is our intention to conduct this meeting in accordance with these documents. There will be an opportunity for questions about the proposals prior to voting. Please adhere to the rules of conduct attached to your agenda in addressing this meeting in connection with the proposals. If you have sent in a proxy, your vote will be counted automatically without any further action on your part. If you are eligible to vote and have not submitted your proxy or if you want to change your vote, please click on the stockholder ballot link on the web portal and follow the instructions. The inspector of elections has advised that a quorum is present at the meeting. After the review of the proposals, we will provide time for questions pertinent to the meeting matters. Only validated stockholders may ask questions through the Ask A Question box located on the meeting website. Out of consideration for others, please limit yourself to 2 questions. The first item of business stated in the notice of annual meeting of stockholders is to elect 6 individuals to our Board of Directors who will serve until the 2022 annual meeting of stockholders. Joshua R. Disbrow, Gary V. Cantrell; Carl C. Dockery; John A. Donofrio Jr.; Michael E. Macaluso and Steven J. Boyd have been nominated. The next order of business is to approve the ratification of Plante Moran as our independent registered public accounting firm for the fiscal year ending June 30, 2021. We will now open the floor to questions concerning the matters to be voted upon. If you would like to ask a question, please enter them through the Ask A Question box located on the meeting website. It is now 10:02 Mountain Time, and the polls for each matter to be voted on at this annual meeting are now open. Stockholders who are voting via the web portal, please submit your vote now. You must submit your votes via the web portal now in order for them to be counted. The inspector of elections will not accept proxies or votes or any changes or revocations submitted after the closing of the polls. Pursuant to their standard procedures, the inspector of elections will tabulate the votes in accordance with such procedures. The results of the balloting will be certified by the inspector of elections. Upon certification, the company will publicly announce the results of the voting on items presented at this meeting. We ask now, if you have not already, please vote. [Voting]

Joshua Disbrow

executive
#2

We have received the shareholder votes, and I declare the polls closed. It is now 10:03 Mountain. And the meeting is now adjourned. This ends the formal portion of our meeting. I would like to express my sincere appreciation to the stockholders who attended the meeting and voted as well as those who submitted their proxies but were not able to attend -- to be present virtually. Thank you for your time, and have a good weekend.

For developers and AI pipelines

Programmatic access to Aytu BioPharma, Inc. earnings transcripts and 32,000+ others is available through the EarningsCalls.dev REST API. Plans from $24.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.